跳至主要内容
临床试验/NCT03073837
NCT03073837已完成不适用

RUDOLPH Study Nasal Microbiota and Concurrent Nose Soreness Associated With Common Cold Infection - a Pilot Using the HRV-16 Challenge Model in Healthy Subjects

Kimberly-Clark Corporation2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2017年3月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
2
主要终点
nasal microbiota composition and occurrence of nose redness and soreness during rhinovirus infection

研究概览

简要总结

This pilot study will utilize the experimental rhinovirus infection model to study changes in skin microbiota in relation to skin erythema and soreness.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • self reported proneness to developing symptoms of nose redness and/or soreness
  • sero-negative to HRV-16 at screening

排除标准

  • confirmed or self-reported allergic rhinitis
  • history of nasal or otologic surgery
  • use of anti-inflammatory medication, recent antibiotics or anti-histamines

研究组 & 干预措施

Rhinovirus Challenge

Other

Challenge with HRV-16

干预措施: Rhinovirus Challenge (Other)

结局指标

主要结局

nasal microbiota composition and occurrence of nose redness and soreness during rhinovirus infection

时间窗: change from baseline compared to day 22

Taxonomic classification of bacterial strains before and after HRV-16 virus for subjects with a VAS score rating \>37mm

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验